83 FR 57740 - Center for Scientific Review; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 83, Issue 222 (November 16, 2018)
National Institutes of Health
Federal Register Volume 83, Issue 222 (November 16, 2018)
| Page Range | 57740-57741 | |
| FR Document | 2018-24999 |
[Federal Register Volume 83, Number 222 (Friday, November 16, 2018)] [Notices] [Pages 57740-57741] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-24999] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which [[Page 57741]] would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: AIDS and AIDS Related Research. Date: December 4, 2018. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Barna Dey, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3184, Bethesda, MD 20892, 301-451-2796, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Structure/Function Relationships. Date: December 6, 2018. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Peter B. Guthrie, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4142, MSC 7850, Bethesda, MD 20892, (301) 435-1239, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Adult Cognition, Perception, and Psychopathology. Date: December 6, 2018. Time: 3:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Wind Cowles, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3172, Bethesda, MD 20892, 301-437-7872, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Cancer Immunopathology and Immunotherapy. Date: December 6, 2018. Time: 12:00 p.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Nicholas J. Donato, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4040, Bethesda, MD 20892, 301- 827-4810, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Role of Maternal-Child Interactions in Brain Development Related Disorders. Date: December 7, 2018. Time: 11:00 a.m. to 12:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Seetha Bhagavan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD 20892, (301) 237-9838, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR-17-340: HIV Protease Evolution and Drug Resistance. Date: December 7, 2018. Time: 12:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Eduardo A. Montalvo, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5108, MSC 7852, Bethesda, MD 20892, (301) 435-1168, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Topics in Molecular Cellular Endocrinology. Date: December 10, 2018. Time: 1:00 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Liliana N. Berti-Mattera, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, RM 4215, Bethesda, MD 20892, 301-827- 7609, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: AIDS and AIDS Related Research. Date: December 11, 2018. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Barna Dey, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3184, Bethesda, MD 20892, 301-451-2796, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846- 93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: November 9, 2018. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018-24999 Filed 11-15-18; 8:45 am] BILLING CODE 4140-01-P
![57740 Federal Register / Vol. 83, No. 222 / Friday, November 16, 2018 / Notices
James Berger, MS, MT (ASCP), SBB, non-federal public members consist of should include, at a minimum, the
Senior Advisor for Blood and Tissue representatives of the following following for each nominee: (1) A letter
Policy, Office of HIV/AIDS and categories: Physicians and other medical of nomination that clearly states the
Infectious Disease Policy, Office of the providers with experience in diagnosing name and affiliation of the nominee, the
Assistant Secretary for Health, U.S. and treating tick-borne diseases; basis for the nomination, and a
Department of Health and Human scientists or researchers with expertise; statement from the nominee that
Services, 330 C Street SW, Room L001 patients and their family members; and indicates that the individual is willing
Switzer Building, Washington, DC nonprofit organizations that advocate to serve as a member of the Working
20201. for patients with respect to tick-borne Group, if selected; (2) the nominator’s
FOR FURTHER INFORMATION CONTACT: disease. Individuals who are appointed name, address, and daytime telephone
James Berger, MS, MT (ASCP), SBB, to represent federal entities are number, and the address, telephone
Senior Advisor for Blood and Tissue classified as regular government number, and email address of the
Policy; Telephone: (202) 795–7608; Fax: employees. The public members are individual being nominated; and (3) a
(202) 691–2101; Email address: classified as special government current copy of the nominee’s
tickbornedisease@hhs.gov. Website employees. Invitations of membership is curriculum vitae or resume, which must
information about activities of the extended to other agencies and offices of be limited to no more than 10 pages.
Working Group, as well as the charter the Department of Health and Human Every effort will be made to ensure
for the Working Group, which has been Services and other individuals as that the Working Group is a diverse
filed with the Library of Congress, can determined by the Secretary to be group of individuals with representation
be found at https://www.hhs.gov/ash/ appropriate and beneficial for from various geographic locations, racial
advisory-committees/tickbornedisease/ accomplishing the mission of the and ethnic minorities, all genders, and
index.html. Working Group. persons living with disabilities.
The federal members are appointed to Individuals being considered for
SUPPLEMENTARY INFORMATION: Section serve for the duration of time that the appointment as public voting members
2062 of the 21st Century Cures Act Working Group is authorized to operate. will be required to complete and submit
requires establishment of the Tick-Borne Participation of the appointed federal a report of their financial holdings. An
Disease Working Group. The Working members is at the discretion of their ethics review must be conducted to
Group is governed by provisions of the respective agency head. The public ensure that individuals appointed as
Federal Advisory Committee Act, Public members are invited to serve public voting members of the Working
Law 92–463, as amended (5 U.S.C. overlapping terms of up to four years. Group are not involved in any activity
App.), which sets forth standards for the Any public member who is appointed to that may pose a potential conflict of
formation and use of federal advisory fill the vacancy of an unexpired term interest for the official duties that are to
committees. The 21st Century Cures Act will be appointed to serve for the be performed. This is a federal ethics
is intended to advance the research and remainder of that term. A non-federal requirement that must be satisfied upon
development of new therapies and public member may serve after the entering the position and annually
diagnostics and make substantial federal expiration of their term until their throughout the established term of
investments in a wide range of health successor has taken office, but no longer appointment on the Working Group.
priorities. The Working Group is a non- than 180 days. Terms of more than two
discretionary federal advisory Dated: November 5, 2018.
years are contingent upon renewal of
committee. the charter of the Working Group. James J. Berger,
Objectives and Scope of Activities. Pursuant to advance written agreement, Senior Advisor for Blood and Tissue Policy,
The Secretary of Health and Human public members of the Working Group Designated Federal Officer, Tick-Borne
Services is responsible for ensuring the will receive no stipend for the advisory Disease Working Group.
conduct of and support for service that they render as members of [FR Doc. 2018–25082 Filed 11–15–18; 8:45 am]
epidemiological, basic, translational, the Working Group. However, public BILLING CODE 4150–28–P
and clinical research related to vector- members will receive per diem and
borne diseases, including tick-borne reimbursement for travel expenses
diseases. The Working Group provides incurred in relation to performing duties DEPARTMENT OF HEALTH AND
assistance for this effort. The Working for the Working Group, as authorized by HUMAN SERVICES
Group membership provides expertise law under 5 U.S.C. 5703 for persons
and reviews all efforts within the National Institutes of Health
who are employed intermittently to
Department of Health and Human perform services for the federal Center for Scientific Review; Notice of
Services related to all tick-borne government and in accordance with Closed Meetings
diseases, to help ensure interagency federal travel regulations.
coordination and minimize overlap, and Estimated Number and Frequency of Pursuant to section 10(d) of the
to examine research priorities. Meetings. The Working Group will meet Federal Advisory Committee Act, as
Membership and Designation. The not less than twice a year. The meetings amended, notice is hereby given of the
Working Group consists of 14 voting will be open to the public, except as following meetings.
members who represent diverse determined otherwise by the Secretary, The meetings will be closed to the
scientific disciplines and views. The or another official to whom authority public in accordance with the
composition includes seven federal has been delegated, in accordance with provisions set forth in sections
members and seven public members. the guidelines under Government in the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
amozie on DSK3GDR082PROD with NOTICES
The federal members consist of one or Sunshine Act, 5 U.S.C. 552b(c). as amended. The grant applications and
more representatives of each of the Nominations: Nominations, including the discussions could disclose
following HHS agencies: Office of the self-nominations, of individuals who confidential trade secrets or commercial
Assistant Secretary for Health, the Food have the specified expertise and property such as patentable material,
and Drug Administration, the Centers knowledge will be considered for and personal information concerning
for Disease Control and Prevention, and appointment as public voting members individuals associated with the grant
the National Institutes of Health. The of the Working Group. A nomination applications, the disclosure of which
VerDate Sep<11>2014 17:19 Nov 15, 2018 Jkt 247001 PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 E:\FR\FM\16NON1.SGM 16NON1](https://thefederalregister.org/doc/83_FR_57962/page/1.svg)
![Federal Register / Vol. 83, No. 222 / Friday, November 16, 2018 / Notices 57741
would constitute a clearly unwarranted Agenda: To review and evaluate grant DEPARTMENT OF HEALTH AND
invasion of personal privacy. applications. HUMAN SERVICES
Place: National Institutes of Health, 6701
Name of Committee: Center for Scientific Rockledge Drive, Bethesda, MD 20892,
Review Special Emphasis Panel; Member National Institutes of Health
(Telephone Conference Call).
Conflict: AIDS and AIDS Related Research. Contact Person: Seetha Bhagavan, Ph.D.,
Date: December 4, 2018. National Institute of Allergy and
Scientific Review Officer, Center for Infectious Diseases; Notice of Closed
Time: 10:00 a.m. to 5:00 p.m. Scientific Review, National Institutes of
Agenda: To review and evaluate grant Meetings
Health, 6701 Rockledge Drive, Room 5194,
applications.
MSC 7846, Bethesda, MD 20892, (301) 237– Pursuant to section 10(d) of the
Place: National Institutes of Health, 6701
9838, bhagavas@csr.nih.gov. Federal Advisory Committee Act, as
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting). Name of Committee: Center for Scientific amended, notice is hereby given of the
Contact Person: Barna Dey, Ph.D., Review Special Emphasis Panel; PAR–17– following meetings.
Scientific Review Officer, Center for 340: HIV Protease Evolution and Drug The meetings will be closed to the
Scientific Review, National Institutes of Resistance. public in accordance with the
Health, 6701 Rockledge Drive, Room 3184, Date: December 7, 2018. provisions set forth in sections
Bethesda, MD 20892, 301–451–2796, bdey@ Time: 12:00 p.m. to 3:00 p.m. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
mail.nih.gov. Agenda: To review and evaluate grant as amended. The grant applications and
applications.
Name of Committee: Center for Scientific the discussions could disclose
Place: National Institutes of Health, 6701
Review Special Emphasis Panel; Member confidential trade secrets or commercial
Conflict: Structure/Function Relationships. Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call). property such as patentable material,
Date: December 6, 2018. and personal information concerning
Time: 1:00 p.m. to 4:00 p.m. Contact Person: Eduardo A. Montalvo,
Ph.D., Scientific Review Officer, Center for individuals associated with the grant
Agenda: To review and evaluate grant
applications. Scientific Review, National Institutes of applications, the disclosure of which
Place: National Institutes of Health, 6701 Health, 6701 Rockledge Drive, Room 5108, would constitute a clearly unwarranted
Rockledge Drive, Bethesda, MD 20892, MSC 7852, Bethesda, MD 20892, (301) 435– invasion of personal privacy.
(Telephone Conference Call). 1168, montalve@csr.nih.gov.
Name of Committee: National Institute of
Contact Person: Peter B. Guthrie, Ph.D., Name of Committee: Center for Scientific Allergy and Infectious Diseases, Special
Scientific Review Officer, Center for Review Special Emphasis Panel; Topics in Emphasis Panel; NIAID, 2018 Omnibus BAA
Scientific Review, National Institutes of Molecular Cellular Endocrinology. (HHS–NIH–NIAID–BAA2018) Research Area
Health, 6701 Rockledge Drive, Room 4142, Date: December 10, 2018. 002: Advanced Development of Vaccine
MSC 7850, Bethesda, MD 20892, (301) 435– Time: 1:00 p.m. to 2:30 p.m. Candidates for Biodefense and Emerging
1239, guthriep@csr.nih.gov. Agenda: To review and evaluate grant Infectious Diseases.
Name of Committee: Center for Scientific applications. Date: December 6–7, 2018.
Review Special Emphasis Panel; Member Place: National Institutes of Health, 6701 Time: 10:00 a.m. to 4:00 p.m.
Conflict: Adult Cognition, Perception, and Rockledge Drive, Bethesda, MD 20892, Agenda: To review and evaluate contract
Psychopathology. (Telephone Conference Call). proposals.
Date: December 6, 2018. Contact Person: Liliana N. Berti-Mattera, Place: National Institutes of Health, 5601
Time: 3:00 p.m. to 5:00 p.m. Ph.D., Scientific Review Officer, Center for Fishers Lane, Rockville, MD 20892
Agenda: To review and evaluate grant Scientific Review, National Institutes of (Telephone Conference Call).
applications. Health, 6701 Rockledge Drive, RM 4215, Contact Person: Kelly Y. Poe, Ph.D.,
Place: National Institutes of Health, 6701 Bethesda, MD 20892, 301–827–7609, Scientific Review Officer, Scientific Review
Rockledge Drive, Bethesda, MD 20892, liliana.berti-mattera@nih.gov. Program, Division of Extramural Activities,
(Telephone Conference Call). Room 3F40B, National Institutes of Health,
Name of Committee: Center for Scientific NIAID, 5601 Fishers Lane, MSC 9823,
Contact Person: Wind Cowles, Ph.D., Review Special Emphasis Panel; Member
Scientific Review Officer, Center for Bethesda, MD 20892–9823, (240) 669–5036,
Conflict: AIDS and AIDS Related Research. poeky@mail.nih.gov.
Scientific Review, National Institutes of Date: December 11, 2018.
Health, 6701 Rockledge Drive, Room 3172, Name of Committee: National Institute of
Time: 10:00 a.m. to 5:00 p.m.
Bethesda, MD 20892, 301–437–7872, Allergy and Infectious Diseases, Special
Agenda: To review and evaluate grant
cowleshw@csr.nih.gov. Emphasis Panel; NIAID, SBIR Phase II
applications.
Clinical Trial Implementation Cooperative
Name of Committee: Center for Scientific Place: National Institutes of Health, 6701 Agreement (U44 Clinical Trial Required).
Review Special Emphasis Panel; Member Rockledge Drive, Bethesda, MD 20892, Date: December 14, 2018.
Conflict: Cancer Immunopathology and (Virtual Meeting). Time: 1:00 p.m. to 3:00 p.m.
Immunotherapy. Contact Person: Barna Dey, Ph.D., Agenda: To review and evaluate grant
Date: December 6, 2018. Scientific Review Officer, Center for applications.
Time: 12:00 p.m. to 1:00 p.m. Scientific Review, National Institutes of Place: National Institutes of Health, 5601
Agenda: To review and evaluate grant Health, 6701 Rockledge Drive, Room 3184, Fishers Lane, Rockville, MD 20892
applications. Bethesda, MD 20892, 301–451–2796, bdey@ (Telephone Conference Call).
Place: National Institutes of Health, 6701 mail.nih.gov. Contact Person: J. Bruce Sundstrom, Ph.D.,
Rockledge Drive, Bethesda, MD 20892, (Catalogue of Federal Domestic Assistance Scientific Review Officer, Scientific Review
(Telephone Conference Call). Program Nos. 93.306, Comparative Medicine; Program, Division of Extramural Activities,
Contact Person: Nicholas J. Donato, Ph.D., 93.333, Clinical Research, 93.306, 93.333, Room 3G11A, National Institutes of Health/
Scientific Review Officer, Center for 93.337, 93.393–93.396, 93.837–93.844, NIAID, 5601 Fishers Lane, MSC 9823,
Scientific Review, National Institutes of 93.846– 93.878, 93.892, 93.893, National Bethesda, MD 20892–9823, 240–669–5045,
Health, 6701 Rockledge Drive, Room 4040, Institutes of Health, HHS) sundstromj@niaid.nih.gov.
Bethesda, MD 20892, 301–827–4810,
amozie on DSK3GDR082PROD with NOTICES
Name of Committee: National Institute of
nick.donato@nih.gov. Dated: November 9, 2018. Allergy and Infectious Diseases, Special
Name of Committee: Center for Scientific Ronald J. Livingston, Jr., Emphasis Panel; NIAID, Clinical Trial
Review Special Emphasis Panel; Role of Planning Grant (R34).
Program Analyst, Office of Federal Advisory
Maternal-Child Interactions in Brain Date: December 18, 2018.
Committee Policy.
Development Related Disorders. Time: 1:00 p.m. to 3:00 p.m.
Date: December 7, 2018. [FR Doc. 2018–24999 Filed 11–15–18; 8:45 am] Agenda: To review and evaluate grant
Time: 11:00 a.m. to 12:30 p.m. BILLING CODE 4140–01–P applications.
VerDate Sep<11>2014 17:19 Nov 15, 2018 Jkt 247001 PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\16NON1.SGM 16NON1](https://thefederalregister.org/doc/83_FR_57962/page/2.svg)
Document Created: 2018-11-16 07:22:34
Document Modified: 2018-11-16 07:22:34
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | December 4, 2018. | |
| FR Citation | 83 FR 57740 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR